Laxmi Dental Limited — PPTs, 11-08-2026: Investor Presentation

Laxmi Dental kicked off FY27 with a strong Q1, posting record revenue of **₹74.7 Cr**, up 13.9% year-on-year. Profitability also improved, thanks to a better product mix. Growth was broad-based, with the Dental Laboratory business surging 23.5% (international operations up 37.4%) and Aligner Solutions growing 28.6%.

The company's strategy focuses on deepening market penetration via its 22,000+ dental network, scaling branded offerings like Illusion and Taglus, and boosting manufacturing efficiency with AI-led automation. They are also actively expanding digital dentistry with tools like iScanPro.

Recent developments include establishing three new support facilities in India and strengthening U.S. leadership. Notably, Laxmi Dental achieved US FDA 510K approval for its aligners, a first for an Indian company.

Financially, Gross Profit Margin improved to 78.6%. EBITDA rose 20.6% to **₹14.36 Cr** (19.2% margin), and PAT jumped 23.8% to **₹10.32 Cr** (13.8% margin). Basic EPS stood at ₹1.87.

Management expects to deliver sustainable and profitable growth, driven by continued digitalization, innovation, and network expansion.